1 BILLION PATIENTS
Cardiometabolic Diseases
1 BILLION PATIENTS
Cardiometabolic Diseases
Purpose Bio's therapeutics target the key and most critical mechanism of the body's fat absorption and digestion mechanisms, in a specific, non-systemic and first of its kind scientific approach.
With a rich library of Intellectual Property and world class scientific and leadership teams, we are poised to bring real game changing therapeutics to improve and save patients lives across the globe.
UCLA Presents PurposeBio in JPM2025
Among UCLA's 4 Top Life Science Startups
The Team
CEO, Founder
Chair of the Scientific Board
Scientific Co-Founder
Medical Advisor
Scientific Advisory Board
Scientific Advisory Board
Bioinformatics, Lipid Metabolism
Purpose Bio is a UCLA spin out technology
Our Scientific team's academic backgroud and affiliations:
contact us: lital@purposebio.com